Lisa M. Niswander

Hematology | Oncology
3401 Civic Center Blvd
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies.

The Use of Targeted Therapy in Pediatric Acute Lymphoblastic Leukemia: Exploring Novel Approaches and Emerging Therapies.

Journal: Current treatment options in oncology
Published: May 06, 2025

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia.

Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia.

Journal: Leukemia
Published: June 28, 2024

Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.

Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.

Journal: Haematologica
Published: December 23, 2022

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia.

Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia.

Journal: Haematologica
Published: May 24, 2022

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design.

Journal: Journal for immunotherapy of cancer
Published: August 06, 2021

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.

Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia.

Journal: Haematologica
Published: March 03, 2021

Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.

Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.

Journal: Haematologica
Published: May 17, 2020

Long-acting PGE2 and Lisinopril Mitigate H-ARS.

Long-acting PGE2 and Lisinopril Mitigate H-ARS.

Journal: Radiation research
Published: April 26, 2020

Imaging Flow Cytometric Analysis of Primary Bone Marrow Megakaryocytes.

Imaging Flow Cytometric Analysis of Primary Bone Marrow Megakaryocytes.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 28, 2016

SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.

SDF-1 dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury.

Journal: Blood
Published: April 17, 2014

End-of-life care for children enrolled in a community-based pediatric palliative care program.

End-of-life care for children enrolled in a community-based pediatric palliative care program.

Journal: Journal of palliative medicine
Published: March 18, 2014

Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry.

Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: October 11, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026